ID

27684

Description

Study ID: 103094 Clinical Study ID: ARI103094 Study Title: ARI103094-Follow-Up Study for REDUCE Study Subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00883909 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: dutasteride Trade Name: Zytefor,Zyfetor,Duagen,Avolve,Avodart,Avidart Study Indication: Neoplasms, Prostate CRF Seiten: 934-977

Mots-clés

  1. 15/11/2017 15/11/2017 -
  2. 26/11/2017 26/11/2017 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

26 novembre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Investigator data Log GSK study Prostatic neoplasms NCT00883909

Investigator data Log GSK study Prostatic neoplasms NCT00883909

Administrative data
Description

Administrative data

Alias
UMLS CUI-1
C1320722
Session number
Description

Session number

Type de données

integer

Alias
UMLS CUI [1,1]
C1883017
UMLS CUI [1,2]
C0750480
Subject number
Description

Subject number

Type de données

text

Alias
UMLS CUI [1]
C2348585
Investigator Comment Log
Description

Investigator Comment Log

Alias
UMLS CUI-1
C0008961
UMLS CUI-2
C0947611
Date of comment
Description

Date of comment

Type de données

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0947611
CRF page number if applicable
Description

page number CRF

Type de données

integer

Alias
UMLS CUI [1,1]
C1704732
UMLS CUI [1,2]
C1516308
Comment
Description

Comment

Type de données

text

Alias
UMLS CUI [1]
C0947611
Investigator’s Statement
Description

Investigator’s Statement

Alias
UMLS CUI-1
C0008961
UMLS CUI-2
C1710187
Date
Description

Check that the date of signature is on or after the completion of Visit 10.

Type de données

date

Alias
UMLS CUI [1]
C0011008
Investigator’s Signature
Description

Sign and date this page after all relevant CRF pages, including outstanding test results, are completed.

Type de données

text

Alias
UMLS CUI [1]
C2346576
Investigator’s Name - Print
Description

Investigator Name

Type de données

text

Alias
UMLS CUI [1]
C2826892

Similar models

Investigator data Log GSK study Prostatic neoplasms NCT00883909

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Administrative data
C1320722 (UMLS CUI-1)
Session number
Item
Session number
integer
C1883017 (UMLS CUI [1,1])
C0750480 (UMLS CUI [1,2])
Subject number
Item
Subject number
text
C2348585 (UMLS CUI [1])
Item Group
Investigator Comment Log
C0008961 (UMLS CUI-1)
C0947611 (UMLS CUI-2)
Date of comment
Item
Date of comment
date
C0011008 (UMLS CUI [1,1])
C0947611 (UMLS CUI [1,2])
page number CRF
Item
CRF page number if applicable
integer
C1704732 (UMLS CUI [1,1])
C1516308 (UMLS CUI [1,2])
Comment
Item
Comment
text
C0947611 (UMLS CUI [1])
Item Group
Investigator’s Statement
C0008961 (UMLS CUI-1)
C1710187 (UMLS CUI-2)
Date
Item
Date
date
C0011008 (UMLS CUI [1])
Investigator Signature
Item
Investigator’s Signature
text
C2346576 (UMLS CUI [1])
Investigator Name
Item
Investigator’s Name - Print
text
C2826892 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial